Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Mar 2018 11:37

RNS Number : 1404H
Consort Medical PLC
08 March 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Consort Medical Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Polar Capital LLP

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

07/03/2018

6. Date on which issuer notified (DD/MM/YYYY):

08/03/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.04%

5.04%

49,283,719

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

2,485,527

5.04%

SUBTOTAL 8. A

2,485,527

5.04%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London, UK

Date of completion

08/03/2018

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLJPMBTMBJMBRP
Date   Source Headline
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
16th Jul 20193:49 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSIncident at the Aesica Cramlington API Facility
13th Jun 20197:00 amRNSFull Year results
29th May 20198:37 amRNSHolding(s) in Company
28th May 201912:50 pmRNSHolding(s) in Company
21st May 20194:30 pmRNSNotice of Results
15th Apr 20199:21 amRNSBlock listing Interim Review
1st Apr 20199:00 amRNSTotal Voting Rights
19th Mar 20199:14 amRNSHolding(s) in Company
7th Feb 20191:28 pmRNSAGM Voting Update - Director Declaration
31st Jan 20197:00 amRNSDEV610: FDA approval for Mylan's generic Advair
15th Jan 20193:03 pmRNSHolding(s) in Company
2nd Jan 20199:07 amRNSTotal Voting Rights
21st Dec 20187:00 amRNSClosure of American Depositary Receipt Programme
20th Dec 20188:56 amRNSHolding(s) in Company
11th Dec 20189:11 amRNSDirector/PDMR Shareholding
7th Dec 20189:16 amRNSHolding(s) in Company
6th Dec 20185:18 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSInterim Results
3rd Dec 20188:47 amRNSTotal Voting Rights
8th Nov 20183:49 pmRNSDirector/PDMR Shareholding
7th Nov 20182:49 pmRNSHolding(s) in Company
6th Nov 201812:30 pmRNSNotice of Results
6th Nov 20187:00 amRNSDirectorate Change
31st Oct 201811:17 amRNSDirector/PDMR Shareholding
15th Oct 20189:17 amRNSBlock listing Interim Review
10th Oct 20182:24 pmRNSDirector/PDMR Shareholding
9th Oct 201810:46 amRNSDirector/PDMR Shareholding
2nd Oct 201812:57 pmRNSDirector/PDMR Shareholding
1st Oct 20189:08 amRNSTotal Voting Rights
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSConsort Signs Development Agreements with Opiant
6th Sep 20183:47 pmRNSDirector/PDMR Shareholding
5th Sep 20184:41 pmRNSResult of AGM
3rd Sep 20188:20 amRNSTotal Voting Rights
23rd Aug 20184:51 pmRNSHolding(s) in Company
22nd Aug 20185:21 pmRNSDirector/PDMR Shareholding
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
8th Aug 20182:58 pmRNSForm 8.3 - Consort Medical Plc
7th Aug 20183:20 pmRNSForm 8.3 - Consort Medical plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
6th Aug 20183:11 pmRNSForm 8.3 - Consort Medical PLC
6th Aug 20189:28 amRNSForm 8.3 - Consort Medical plc
3rd Aug 20183:08 pmRNSForm 8.3 - Consort Medical PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.